These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3448488)

  • 1. Increase in liver-associated natural killer activity by polyribonucleotides.
    Twilley TA; Mason L; Talmadge JE; Wiltrout RH
    Nat Immun Cell Growth Regul; 1987; 6(6):279-90. PubMed ID: 3448488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation of natural killer activity by polyribonucleotides.
    Wiltrout RH; Salup RR; Twilley TA; Talmadge JE
    J Biol Response Mod; 1985 Oct; 4(5):512-7. PubMed ID: 4078596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of natural killer cells in newborn piglets by interferon induction.
    Lesnick CE; Derbyshire JB
    Vet Immunol Immunopathol; 1988 Mar; 18(2):109-17. PubMed ID: 2838948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2.
    Talmadge JE; Herberman RB; Chirigos MA; Maluish AE; Schneider MA; Adams JS; Philips H; Thurman GB; Varesio L; Long C
    J Immunol; 1985 Oct; 135(4):2483-91. PubMed ID: 2411797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response modifying activity in mice of polyinosinic: polycytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly-ICLC].
    Chirigos MA; Papademetriou V; Bartocci A; Read E; Levy HB
    Int J Immunopharmacol; 1981; 3(4):329-37. PubMed ID: 7333719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of hyporesponsiveness to augmentation of natural killer cell activity after multiple doses of maleic anhydride divinyl ether: association with decreased numbers of large granular lymphocytes.
    Saito T; Welker RD; Fukui H; Herberman RB; Chirigos MA
    Cell Immunol; 1985 Feb; 90(2):577-89. PubMed ID: 3871375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2.
    Zhang SR; Salup RR; Urias PE; Twilley TA; Talmadge JE; Herberman RB; Wiltrout RH
    Cancer Immunol Immunother; 1986; 21(1):19-25. PubMed ID: 3484675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate-specific proteases (BLT-esterase) are localized predominantly in the natural killer cells of unprimed mice.
    Sayers TJ; Mason LH; Pilaro A; Wiltrout TA; Komschlies K; Munger WL; Wiltrout RH
    J Leukoc Biol; 1993 Apr; 53(4):454-61. PubMed ID: 8482926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection.
    McIntyre KW; Welsh RM
    J Exp Med; 1986 Nov; 164(5):1667-81. PubMed ID: 3490535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
    Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
    J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.
    Ewel CH; Urba WJ; Kopp WC; Smith JW; Steis RG; Rossio JL; Longo DL; Jones MJ; Alvord WG; Pinsky CM
    Cancer Res; 1992 Jun; 52(11):3005-10. PubMed ID: 1591717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow.
    Wiltrout RH; Pilaro AM; Gruys ME; Talmadge JE; Longo DL; Ortaldo JR; Reynolds CW
    J Immunol; 1989 Jul; 143(1):372-8. PubMed ID: 2732472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyporeactivity to interferon induction in newborn piglets.
    Derbyshire JB; Lesnick CE
    J Interferon Res; 1990 Feb; 10(1):47-53. PubMed ID: 1691769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tumor burden and route of administration on the immunotherapeutic properties of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethyl cellulose [Poly(I,C)-LC].
    Black PL; Hartmann D; Pennington R; Phillips H; Schneider M; Tribble HR; Talmadge JE
    Int J Immunopharmacol; 1992 Nov; 14(8):1341-53. PubMed ID: 1464467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models.
    Zhu X; Nishimura F; Sasaki K; Fujita M; Dusak JE; Eguchi J; Fellows-Mayle W; Storkus WJ; Walker PR; Salazar AM; Okada H
    J Transl Med; 2007 Feb; 5():10. PubMed ID: 17295916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of correlation between interferon levels induced by polyribonucleotides and their antimetastatic effect.
    Sakurai M; Iigo M; Sasaki Y; Nakagawa K; Fujiwara Y; Tamura T; Ohe Y; Bungo M; Saijo N
    Oncology; 1990; 47(3):251-6. PubMed ID: 1692985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between large granular lymphocytes and NK-1.2+ cells from normal and poly(inosinic:cytidylic acid) (poly(I:C]-treated mice.
    Alberti S; Luini W; Pasqualetto E; Allegrucci M; Spreafico F; Patterson S; Grindley H; Alberti E; Colotta F
    Clin Immunol Immunopathol; 1985 Jul; 36(1):81-94. PubMed ID: 4006323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and therapeutic activity of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethylcellulose [poly(I,C)-LC].
    Chirigos MA; Schlick E; Ruffmann R; Budzynski W; Sinibaldi P; Gruys E
    J Biol Response Mod; 1985 Dec; 4(6):621-7. PubMed ID: 4087033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
    Talmadge JE; Adams J; Phillips H; Collins M; Lenz B; Schneider M; Schlick E; Ruffmann R; Wiltrout RH; Chirigos MA
    Cancer Res; 1985 Mar; 45(3):1058-65. PubMed ID: 3155990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly-ICLC preconditioning protects the blood-brain barrier against ischemic injury in vitro through type I interferon signaling.
    Gesuete R; Packard AE; Vartanian KB; Conrad VK; Stevens SL; Bahjat FR; Yang T; Stenzel-Poore MP
    J Neurochem; 2012 Nov; 123 Suppl 2(Suppl 2):75-85. PubMed ID: 23050645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.